1:59 Immunological Mechanism Defense Against COPD Pathogens March 18, 2023 • Allergy / Immunology @DanielEnosi and coauthors demonstrate #immune defense against #COPD #pathogens.
6:40 Successful Treatment-Free Remission in Patients With CML After TKI Discontinuation November 18, 2022 • CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses treatment-free remission in #CML.
1:02 Votobatinib Promising in Phase 1/2 Trial of Mostly Heavily Pretreated CML Patients November 1, 2022 • CML Content Hub @GCC_Cortes, of @GACancerCenter, discusses #votobatinib in #CML.
1:37:47 Small Molecule Inhibitor Reduces Glycogen in Preclinical Mouse Models of Pompe Disease October 13, 2022 • Pompe Disease Content Hub Julie Ullman, PhD, of @MazeInBiotech, discusses #preclinical #results on #MZE001 for #PompeDisease.
5:28 Liquid Biopsy in Lung Cancer Decreases Time to Treatment June 20, 2022 • Oncology Miguel Garcia-Pardo, MD, of @pmcancercentre, discusses #liquidbiopsy in #lungcancer.
18:03 The Impact of Biologic Therapy on IBD Surgical Management March 11, 2022 • Ulcerative Colitis Content Hub @JasonFrischerMD of @CincyChildrens discusses the impact of biologics on IBD surgery.
51:47 Podcast: Data From the True North Study March 9, 2022 • Ulcerative Colitis Content Hub @KakodkarSamir discusses #ozanimod based on the #TRUENORTH study.
2:58 Vitamin D May Reduce Risk of Autoimmune Disorders, Including Rheumatoid Arthritis March 8, 2022 • Rheumatoid Arthritis Content Hub JoAnn Manson, MD, MPH, DrPH, of @BrighamWomens, discusses results of the #VITAL trial.
9:43 Phase 2b Data for Guselkumab in Ulcerative Colitis March 7, 2022 • Ulcerative Colitis Content Hub Axel Dignass, MD, PhD, Goethe University, discusses findings from the phase 2b QUASAR study.
5:45 Recent Study on Combination of Guselkumab and Golimumab in Ulcerative Colitis March 3, 2022 • Ulcerative Colitis Content Hub Bruce Sands, MD, MS, from @IcahnMountSinai, discusses a combination therapy in #ulcerativecolitis.
